We are live on
!
Find out more
GC
Globeflex Capital Portfolio holdings
AUM
$661M
1-Year Est. Return
50.59%
This Fund
S&P 500
This Quarter
Est. Return
-16.26%
1 Year Est. Return
+50.59%
3 Year Est. Return
+135.47%
5 Year Est. Return
+202.82%
10 Year Est. Return
+1,069.65%
AUM
$420M
AUM Growth
-$88.6M
(-17%)
Cap. Flow
+$8.06M
Cap. Flow
% of AUM
1.92%
Top 10 Holdings %
Top 10 Hldgs %
15.09%
Holding
474
New
39
Increased
96
Reduced
125
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HMLP
HOEGH LNG PARTNERS LP
HMLP
|
+$4.57M |
| 2 |
Bank of N.T. Butterfield & Son
NTB
|
+$4.44M |
| 3 |
DESP
Despegar.com
DESP
|
+$4.43M |
| 4 |
Luxfer Holdings
LXFR
|
+$3M |
| 5 |
AudioCodes
AUDC
|
+$2.81M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TARO
Taro Pharmaceutical Industries Ltd.
TARO
|
+$7.12M |
| 2 |
Icon
ICLR
|
+$6.07M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$2.38M |
| 4 |
TVPT
Travelport Worldwide Limited
TVPT
|
+$2.31M |
| 5 |
ARRS
ARRIS International plc Ordinary Shares
ARRS
|
+$1.81M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 17.76% |
| 2 | Healthcare | 17.11% |
| 3 | Technology | 14.51% |
| 4 | Consumer Discretionary | 14.11% |
| 5 | Financials | 12% |
Similar funds
HIG
RCG
FM
ACM
UCMOK
DC
FAM
CAM
Globeflex Capital's Q4 2018 Portfolio in Review
As of Q4 2018, Globeflex Capital held 474 positions worth $420M, down 17% from $509M the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Globeflex Capital's Q4 2018 filing shows 39 new, 96 increased, 125 reduced and 44 closed positions. Its largest new stake was HOEGH LNG PARTNERS LP: 267,276 shares worth $4.1M. The largest sale was Taro Pharmaceutical Industries Ltd., an estimated $7.12M.
By sector, the portfolio is most concentrated in Industrials at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Technology.
- Globeflex Capital's largest Q4 2018 buy was HOEGH LNG PARTNERS LP: 267,276 shares worth $4.1M.
- Globeflex Capital added most to Bank of N.T. Butterfield & Son in Q4 2018, an estimated $4.44M increase.
- Globeflex Capital's biggest Q4 2018 reduction was Icon, cutting an estimated $6.07M.
- Globeflex Capital fully exited Taro Pharmaceutical Industries Ltd. in Q4 2018, selling an estimated $7.12M.
- Globeflex Capital's ten largest holdings make up 15% of its $420M portfolio in Q4 2018.
- Globeflex Capital opened 39 new positions and closed 44 in Q4 2018.
- Globeflex Capital's portfolio value fell 17% quarter-over-quarter to $420M.
Based on Globeflex Capital's 13F filing for Q4 2018, filed 14 Feb 2019.